Substance / Medication

Abarelix

Overview

Active Ingredient
abarelix
RxNorm CUI
301739

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Research Evidence

Published studies and systematic reviews

Sort:
Dose-escalated abarelix in androgen-independent prostate cancer: a phase I study.
Beer Tomasz M, Ryan Christopher, Bhat Gajanan et al. · Anticancer Drugs · 2006
PMID: 17001181Trial
An open-label study of abarelix in men with symptomatic prostate cancer at risk of treatment with LHRH agonists.
Koch Michael, Steidle Christopher, Brosman Stanley et al. · Urology · 2003
PMID: 14624912Trial
A phase 3, multicenter, open label, randomized study of abarelix versus leuprolide plus daily antiandrogen in men with prostate cancer.
Trachtenberg John, Gittleman Marc, Steidle Christopher et al. · J Urol · 2002
PMID: 11912385Trial
Technology evaluation: Abarelix, Praecis pharmaceuticals.
Doehn C, Jocham D · Curr Opin Mol Ther · 2000
PMID: 11249760Trial

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Abarelix (substance)
SNOMED CT
407128008
UMLS CUI
C0965390
RxNorm CUI
301739

Clinical Data

This intervention maps to 5 entities in the Ltrl knowledge graph.

1
Conditions
1
Biomarkers
2
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.